Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,708,762
-
Share change
-
-961,318
-
Total reported value
-
$211,371,380
-
Price per share
-
$4.43
-
Number of holders
-
86
-
Value change
-
-$8,235,898
-
Number of buys
-
34
-
Number of sells
-
36
Institutional Holders of MAGENTA THERAPEUTICS INC - COM (MGTA) as of Q4 2021
As of 31 Dec 2021,
MAGENTA THERAPEUTICS INC - COM (MGTA) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,708,762 shares.
The largest 10 holders included
TRV GP IV, LLC, Deep Track Capital, LP, Casdin Capital, LLC, GILDER GAGNON HOWE & CO LLC, Atlas Venture Life Science Advisors, LLC, Alphabet Inc., Aquilo Capital Management, LLC, ORBIMED ADVISORS LLC, TCG Crossover Management, LLC, and BlackRock Inc..
This page lists
86
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.